Doxorubicin Hydrochloride Injectable, Liposomal
Product Images NDC 68001-704

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 68001-704). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (6ba8cf1f 0639 4db5 A864 37077551bb70 01)

FDA Label Image

Image (6ba8cf1f 0639 4db5 A864 37077551bb70 02)

FDA Label Image

Image (6ba8cf1f 0639 4db5 A864 37077551bb70 03)

This text appears to be a chemical formula involving various elements such as carbon, hydrogen, nitrogen, and oxygen with specific structural arrangements. The formula mentions the presence of compounds like HC, CH, N, O, and P. The values of m and n seem to be specified as either 14 or 16.*

FDA Label Image

Image (6ba8cf1f 0639 4db5 A864 37077551bb70 04)

This is a description of a MPEG-DSPE coating that consists of an aqueous core with entrapped doxorubicin HCI and a liposomal bilayer. The coating may be used for drug delivery purposes.*

FDA Label Image

Vial Label- Doxorubicin HCl Liposome Injection 20mg/10 mg (6ba8cf1f 0639 4db5 A864 37077551bb70 05)

Description: The text contains information about a pharmaceutical product manufactured by 2ydus Lifesciences Ltd in Ahmedabad, India for BluePoint Laboratories. It provides details about a liposomal formulation of DOXOrubicin Hydrochloride, a cytotoxic agent, and instructions for storage and administration. This product is intended for single-dose use and should be refrigerated at 2° to 8°C. The text emphasizes not freezing the product and discarding any unused portion. It also mentions the importance of dilution before use and warns against substituting the liposomal formulation for DOXORUBICIN Hydrochloride.*

FDA Label Image

Carton (Doxorubicin HCL Liposome Injection 20mg/10ml)

This is a description for a medication called "DOXOrubicin Hydrochloride Liposome Injection". It is a cytotoxic agent that must be diluted before intravenous infusion. The formulation is liposomal and should not be substituted for standard DOXOrubicin Hydrochloride. It should be refrigerated at 2 to 8°C and not frozen. The medication comes in single-dose vials of 10 mL. The recommended dosage should be prescribed by a healthcare professional.*

FDA Label Image

Vial Label (Doxorubicin HCL Liposome Injection 50mg/25ml)

This text provides important information about a medication labeled as R = NDC 68001-704-26 ReOnly S/ 3 DOXOrubicin Hydrochloride. It includes storage instructions such as refrigerating at 2° to 8°C (36° to 46°F), a warning to not freeze the medication, and details about the recommended dosage. It also indicates that the medication is a cytotoxic agent that must be diluted before intravenous infusion and should be retained in the carton until use.*

FDA Label Image

Carton (Doxorubicin HCL Liposome Injection 50mg/25ml)

This is a description of a pharmaceutical product containing an injectable liposome formulation of DOXOrubicin Hydrochloride. It is a cytotoxic agent used for intravenous infusion after dilution. The recommended dosage and administration instructions are provided, emphasizing the importance of proper dilution and storage conditions. The product should be refrigerated at 2° to 8°C and not frozen. Information about the packaging, including a single-dose vial, is also included.*

FDA Label Image

Image (6ba8cf1f 0639 4db5 A864 37077551bb70 130 2)

This document appears to be a statistical analysis of a study comparing the effectiveness of Doxorubicin + Bortezomib versus Bortezomib alone. The results include p-values, hazard ratios, and the number of subjects at risk over time in months. The data seems to show a significant benefit for the combined treatment in terms of survival.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.